跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 999 条关于
“LGN”
全部
999
临床试验
568
药物
364
机构
13
资讯
54
去年
Ultrasound-Activated Nanoparticles Enable Precise Drug Delivery to Deep Brain Regions in Primates
去年
Ligand Pharmaceuticals Leads $75M Royalty Financing for D-Fi Gene Therapy in Rare Skin Disease Trial
3个月前
Ligand Pharmaceuticals Director Sells 2,501 Shares in Pre-Planned Option Exercise — What the Royalty-Driven Biotech Model Means for Investors
10个月前
Pelthos Therapeutics Acquires Xepi for Antibiotic-Resistant Impetigo Treatment and Secures $18 Million Financing
去年
Ligand's Pelthos Therapeutics to Merge with Channel Therapeutics in $50M Deal Focused on Molluscum Treatment
上个月
Ligand Reports 32% Royalty Revenue Growth, Raises EPS Guidance Following XOMA Acquisition
去年
UroGen Pharma Advances Bladder Cancer Pipeline with UGN-102 and UGN-103
2年前
UGN-102 Shows Durable Response in Non-Muscle Invasive Bladder Cancer Trial
去年
FDA Advisory Committee Rejects UroGen's Bladder Cancer Therapy UGN-102
去年
LBS-007 Receives FDA Fast Track Designation for Acute Myeloid Leukemia Treatment
第 1 页,共 6 页
上一页
下一页